Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Return on Equity (2023 - 2025)

Metagenomi (MGX) has disclosed Return on Equity for 3 consecutive years, with 0.52% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 20.0% to 0.52% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.52%, a 20.0% decrease, with the full-year FY2025 number at 0.45%, up 113.0% from a year prior.
  • Return on Equity was 0.52% for Q4 2025 at Metagenomi, down from 0.47% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.01% in Q4 2023 to a low of 1.17% in Q1 2024.
  • A 3-year average of 0.31% and a median of 0.35% in 2025 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -132bps in 2024, then soared 82bps in 2025.
  • Metagenomi's Return on Equity stood at 1.01% in 2023, then crashed by -132bps to 0.32% in 2024, then plummeted by -64bps to 0.52% in 2025.
  • Per Business Quant, the three most recent readings for MGX's Return on Equity are 0.52% (Q4 2025), 0.47% (Q3 2025), and 0.43% (Q2 2025).